Cannabidiol (CBD) for use in the treatment of generalised and/or partial seizures

摘要

Use of the phyto-cannabinoid cannabidiol (CBD) in the treatment of epilepsy and more particularly generalized (tonic-clonic) seizures and/or partial seizures. The daily dose of CBD is preferably at least 400 mg and more preferably 400-800 mg. CBD as an anticonvulsant may be used in combination with tetrahydrocannabivarin (THCV), wherein the daily dose of THCV is preferably at least 1.5 mg and more preferably at least 15 mg. CBD and THCV may be in the form of pure compounds or plant extracts with low contents of tetrahydrocannabinol (THC). The examples disclosed relate to the use of CBD (pure) or THCV (pure or botanical extract) as anti-epileptics.